Shohei Koide, Ph.D. is Professor of Biologics Design in the Biochemistry and Molecular Pharmacology of New York University School of Medicine, and the Director of Cancer Biologics platform at the Perlmutter Cancer Center at NYU Langone Medical Center. Previously he was Professor of Biochemistry and Molecular Biology at the University of Chicago. He has been actively engaged in protein engineering and design over the last two decades. His research seamlessly integrates rational design, directed evolution, structural biology and cell biology to design highly functional but still simple protein molecules, and applies such synthetic proteins as powerful tools for addressing fundamental challenges in biology, medicine and chemistry. He is a pioneer in the field of the so-called antibody mimics or alternative scaffolds. He is the inventor of the FN3 Monobody technology, the most widely adopted non-antibody scaffold system. He has also made important contributions to the development of synthetic antibody technologies.